Navigation Links
GFX: Wrinkle-Killer or Botox(R) Hit-Man?
Date:3/10/2008

NORTH DALLAS, Texas and PLANO, Texas, March 10 /PRNewswire/ -- Tired of frequent Botox injection visits? GFX might be the long-term wrinkle solution for you!

Newly-FDA approved GFX (Glabella Furrow Relaxation) recently arrived in North Texas and is already making waves -- radiofrequency waves, to be exact -- in select aesthetic centers and cosmetic surgery offices. GFX is a unique technological advancement in facial rejuvenation that offers long-term relaxation of overactive 'frown' muscles; a proposition likely to thrill many long-time Botox users, but one that targets the Botox(R) empire for a kill-shot where it would hurt the most ... right between the eyebrows.

Botox(R) muscle-relaxing injection results typically last from 3 to 4 months on average, while the results of one in-office GFX (sometimes called 'No-tox') treatment averages 18 months or longer. According to Jeffrey Adelglass, M.D., F.A.C.S., a popular North Dallas area cosmetic surgeon who has had plenty of experience working with a variety of cosmetic injectables, treatment of the glabella area alone constitutes approximately 65% -- the lion's share -- of his Botox injections. While his GFX patients might still receive periodic Botox(R) injections in other forehead areas (GFX is currently only FDA-approved for the glabella), sometimes keeping the glabella relaxed can, over time, soften wrinkles in other forehead areas, as well. An observed effect of the treatment has been that eyebrows gradually tend to become more elevated and horizontal forehead lines reduced, potentially eliminating the need for elective surgery or neurotoxin injections entirely for some aesthetic patients.

How does GFX work? This minimally-invasive, in-office procedure utilizes a specified dose of radiofrequency (RF) thermal energy, delivered through an insulated bipolar needle inserted near the eyebrows, on either side of the forehead. First, the doctor delivers a stimulating pulse through the needle tome and recovery.

Contact:

Pamela Fox, Director of Communications, 972-620-3223


'/>"/>
SOURCE SKINTASTIC Medical and Surgical Rejuvenation Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AAFPRS Speaks to the Safety of BOTOX(R) Cosmetic
2. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... Doctors on Liens ... of esteemed ophthalmologist, Dr. Steven H. Rauchman, practicing at North Valley Eye Medical ... accidents, product liability, premise liability and other personal injury cases. These injuries have ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National ... organizations, advocates, and individuals join together to increase recognition about the risks of ... lives. , “Today we mark a nationwide movement to raise awareness about a ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus ... the latest innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems ... pain management, to accelerate tissue synthesis and provide a faster and more efficient ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The SeniorCare Investor ... 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of ... part of the Interactive Webinar Series. , If you want to find out what ...
(Date:2/22/2017)... Marlton, NJ (PRWEB) , ... February 22, 2017 ... ... has served military veterans who suffer from combat-related PTSD. , Established in 1977, ... During the Vietnam-era, the challenges of military returning to civilian life were evident ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Feb. 22, 2017 Summary Provides ... partnering deals and agreements entered into by the worlds ... http://www.reportlinker.com/p03605668-summary/view-report.html Description The Global Non-Small Cell Lung ... understanding and access to partnering deals and agreements entered ... - Trends in partnering deals - Top deals ...
(Date:2/22/2017)... , February 22, 2017 Arthroscopy Devices Market Report, published ... in 2015 and is projected to reach $5,334 million by 2022, growing at a ... of the total market in 2015. Continue Reading ... ... ...
(Date:2/22/2017)... MERIDEN, Conn. , Feb. 22, 2017   ... and maker of Flublok® Influenza Vaccine , announced ... The Partnership for Influenza Vaccine Introduction (PIVI) and the ... the devastating impacts of the flu.  The doses of ... of Mongolia for health care ...
Breaking Medicine Technology: